A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Clinical trial NCT05882045 · COMPLETED
Trial details
- NCT number
- NCT05882045
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-30
- Primary completion
- 2026-04-16
- Enrollment
- 1946
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.